Unknown

Dataset Information

0

Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).


ABSTRACT: BACKGROUND:Higher body mass index (BMI) is associated with lower circulating levels of N-terminal-pro-b-type natriuretic peptide (NT-proBNP). The Interaction between BMI and NT-proBNP with respect to clinical outcomes is not well characterized in patients with acute heart failure. METHODS AND RESULTS:A total of 686 patients from the biomarker substudy of the ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated HF ) clinical trial with documented NT-proBNP levels at baseline were included in the present analysis. Patients were classified by the World Health Organization obesity classification (nonobese: BMI <30 kg/m2, Class I obesity: BMI 30-34.9 kg/m2, Class II obesity BMI 35-39.9 kg/m2, and Class III obesity BMI ?40 kg/m2). We assessed baseline characteristics and 30- and 180-day outcomes by BMI class and explored the interaction between BMI and NT-proBNP for these outcomes. Study participants had a median age of 67 years (55, 78) and 71% were female. NT-proBNP levels were inversely correlated with BMI (P<0.001). Higher NT-proBNP levels were associated with higher 180-day mortality (adjusted hazard ratio for each doubling of NT-proBNP, 1.40; 95% confidence interval, 1.16, 1.71; P<0.001), but not 30-day outcomes. The effect of NT-proBNP on 180-day death was not modified by BMI class (interaction P=0.24). CONCLUSIONS:The prognostic value of NT-proBNP was not modified by BMI in this acute heart failure population. NT-proBNP remains a useful prognostic indicator of long-term mortality in acute heart failure even in the obese patient. CLINICAL TRIAL REGISTRATION:URL: http://www.clinicaltrials.gov. Unique identifier: NCT00475852.

SUBMITTER: Bhatt AS 

PROVIDER: S-EPMC5850232 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).

Bhatt Ankeet S AS   Cooper Lauren B LB   Ambrosy Andrew P AP   Clare Robert M RM   Coles Adrian A   Joyce Emer E   Krishnamoorthy Arun A   Butler Javed J   Felker G Michael GM   Ezekowitz Justin A JA   Armstrong Paul W PW   Hernandez Adrian F AF   O'Connor Christopher M CM   Mentz Robert J RJ  

Journal of the American Heart Association 20180203 3


<h4>Background</h4>Higher body mass index (BMI) is associated with lower circulating levels of N-terminal-pro-b-type natriuretic peptide (NT-proBNP). The Interaction between BMI and NT-proBNP with respect to clinical outcomes is not well characterized in patients with acute heart failure.<h4>Methods and results</h4>A total of 686 patients from the biomarker substudy of the ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated HF ) clinical trial with documented NT-proBN  ...[more]

Similar Datasets

| S-EPMC4581586 | biostudies-literature
| S-EPMC4800112 | biostudies-literature
| S-EPMC2794443 | biostudies-other
| S-EPMC6924269 | biostudies-literature
| S-EPMC6610187 | biostudies-literature
| S-EPMC4456178 | biostudies-literature
| S-EPMC7362664 | biostudies-literature
| S-EPMC8419026 | biostudies-literature
| S-EPMC4512849 | biostudies-literature
| S-EPMC3503538 | biostudies-literature